Dose adjustment of non-vitamin K antagonist oral anticoagulants following acute coronary syndrome and percutaneous coronary intervention in patients with atrial fibrillation

被引：0
作者：
Xing, L. Y. [1 ]
Barcella, C. A. [1 ]
Sindet-Pedersen, C. [1 ]
Bonde, A. N. [1 ]
Gislason, G. [1 ]
Olesen, J. B. [1 ]
机构：
[1] Gentofte Univ Hosp, Dept Cardiol, Copenhagen, Denmark
来源：
EUROPEAN HEART JOURNAL | 2018年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P3841
引用
收藏
页码：819 / 819
页数：1
相关论文
共 50 条
[41]   Patient Guide for Taking the Non-Vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation [J].
Lane, Deirdre A. ;
Wood, Kathryn .
CIRCULATION, 2015, 131 (16) :E412-E415
[42]   Postapproval Observational Studies of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation [J].
Potpara, Tatjana S. ;
Lip, Gregory Y. H. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (11) :1115-1116
[43]   Asian Patients with Stroke plus Atrial Fibrillation and the Dose of Non-Vitamin K Oral Anticoagulants [J].
Bang, Oh Young ;
Hong, Keun-Sik ;
Heo, Ji Hoe .
JOURNAL OF STROKE, 2016, 18 (02) :169-178
[44]   Starting dose and dose adjustment of non-vitamin K antagonist oral anticoagulation agents in a nationwide cohort of patients with atrial fibrillation [J].
L. Gozzo ;
A. Di Lenarda ;
F. Mammarella ;
P. P. Olimpieri ;
A. Cirilli ;
M. Cuomo ;
M. M. Gulizia ;
F. Colivicchi ;
G. Murri ;
S. K. Kunutsor ;
D. Gabrielli ;
F. Trotta .
Scientific Reports, 11
[45]   Starting dose and dose adjustment of non-vitamin K antagonist oral anticoagulation agents in a nationwide cohort of patients with atrial fibrillation [J].
Gozzo, L. ;
Di Lenarda, A. ;
Mammarella, F. ;
Olimpieri, P. P. ;
Cirilli, A. ;
Cuomo, M. ;
Gulizia, M. M. ;
Colivicchi, F. ;
Murri, G. ;
Kunutsor, S. K. ;
Gabrielli, D. ;
Trotta, F. .
SCIENTIFIC REPORTS, 2021, 11 (01)
[46]   Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation with Coronary or Peripheral Artery Disease A Meta-Analysis [J].
Zhang, Hao ;
Xue, Zhengbiao ;
Yi, Dongqian ;
Li, Xiaobo ;
Tan, Yanwu ;
Li, Jianwen .
INTERNATIONAL HEART JOURNAL, 2020, 61 (02) :231-238
[47]   Which should we choose as the anticoagulants for atrial fibrillation patients with coronary stenting? Warfarin vs. non-vitamin K-antagonist oral anticoagulants [J].
Koiwaya, H. ;
Watanabe, N. ;
Ashikaga, K. ;
Nishino, S. ;
Ogata, K. ;
Nakama, T. ;
Matsuura, H. ;
Furugen, M. ;
Kuriyama, N. ;
Shibata, Y. .
EUROPEAN HEART JOURNAL, 2017, 38 :881-882
[48]   Oral Anticoagulation in Japanese Patients With Atrial Fibrillation - Insight to the Use of Non-Vitamin K Antagonist Oral Anticoagulants [J].
Gomez-Molina, Miriam ;
Valdes, Mariano ;
Marin, Francisco .
CIRCULATION JOURNAL, 2015, 79 (02) :292-294
[49]   Adherence to oral anticoagulant therapy in patients with atrial fibrillation Focus on non-vitamin K antagonist oral anticoagulants [J].
Raparelli, Valeria ;
Proietti, Marco ;
Cangemi, Roberto ;
Lip, Gregory Y. H. ;
Lane, Deirdre A. ;
Basili, Stefania .
THROMBOSIS AND HAEMOSTASIS, 2017, 117 (02) :209-218
[50]   Variability in Non-Vitamin K Antagonist Oral Anticoagulants Dose Adjustment in Atrial Fibrillation Patients With Renal Dysfunction: The Influence of Renal Function Estimation Formulae [J].
Andrade, Jason G. ;
Hawkins, Nathaniel M. ;
Fordyce, Christopher B. ;
Deyell, Marc W. ;
Er, Lee ;
Djurdjev, Ognjenka ;
Macle, Laurent ;
Virani, Sean A. ;
Levin, Adeera .
CANADIAN JOURNAL OF CARDIOLOGY, 2018, 34 (08) :1010-1018
12345